|

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

RECRUITINGN/ASponsored by Kuopio University Hospital
Actively Recruiting
PhaseN/A
SponsorKuopio University Hospital
Started2022-11-21
Est. completion2032-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05326750

Summary

Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Mild Cognitive Impairment due to Alzheimer's disease
* Dementia with Lewy Bodies
* Frontotemporal dementia
* Idiopathic normal pressure hydrocephalus (iNPH)

Exclusion Criteria:

* History of seizures
* Pregnancy
* Metal implants in the head (except dental fillings)
* Electronic implants (i.e. pace-maker, implanted medical pump)
* Age \<18 years

Conditions4

Alzheimer DiseaseAlzheimer's DiseaseDementia With Lewy BodiesFrontotemporal Dementia

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.